Nasdaq & Eli Lilly and Company
4 shared events · Importance 3 · Last updated Aug 05, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Nasdaq: Nasdaq confirmed VivoSim's compliance with listing rule 5550(b)(1), allowing continued listing.
Eli Lilly and Company: Eli Lilly made a $5.0 million milestone payment to VivoSim related to the FXR program sale, a routine contractual obligation.
Aug 06, 2026 · 6 articles
Business
Nasdaq: Nasdaq is the exchange where Scribe's shares began trading, benefiting from listing fees and increased trading activity.
Eli Lilly and Company: Eli Lilly has a strategic collaboration with Scribe, which may benefit from Scribe's successful IPO and pipeline progress.
Jul 06, 2026 · 25 articles
Business
Nasdaq: Welcomed SpaceX and SK Hynix listings.
Eli Lilly and Company: Eli Lilly's stock jumped after a committee of the European Medicines Agency recommended one of its medicines for approval, boosting its market performance.
Apr 20, 2026 · 344 articles
Business
Nasdaq: Q32 Bio trades on Nasdaq; the stock surge occurred on this exchange.
Eli Lilly and Company: Eli Lilly's Olumiant is a competitor JAK inhibitor for alopecia areata; positive bempikibart data may increase competition.
Jul 13, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Nasdaq and Eli Lilly and Company interact across events, view sentiment trends, and discover connected entities.
Open Dashboard